Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.00
Bid: 382.50
Ask: 383.50
Change: 6.00 (1.59%)
Spread: 1.00 (0.261%)
Open: 376.00
High: 383.50
Low: 374.00
Prev. Close: 377.00
CHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 Jan 2023 07:00

RNS Number : 4745N
Chemring Group PLC
23 January 2023
 

FOR IMMEDIATE RELEASE 23 JANUARY 2023

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

DIRECTORATE CHANGE

 

After six years as Chief Financial Officer and a director of the Company, Andrew Lewis has informed the Board of his intention to retire. Andrew's notice period is 12 months; he will continue in role to ensure a smooth transition. 

 

The Board has commenced a search process to identify his successor.

 

Chairman of Chemring, Carl-Peter Forster, commented:

 

"Andrew has been a key member of the executive team during a period where Chemring has strongly repositioned itself. His transformation of the Group's finances has placed it in a good position to take advantage of the many opportunities to continue its growth. The Board thanks him for his contribution to Chemring's success and wishes him every success in the future."

 

 

-ENDS-

 

For further information:

 

Rupert Pittman Group Director of Corporate Affairs, 01794 463401

Chemring Group PLC

 

Oliver Hughes MHP Communications 020 3128 8100

Ollie Hoare

 

Notes to editors

 

· Chemring is a FTSE-250 global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

· Employing approximately 2,500 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

· Chemring is organised under two strategic product segments: Sensors & Information and Countermeasures & Energetics

· Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

· Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

Remuneration disclosure

 

Andrew Lewis will be treated in accordance with Chemring's approved remuneration policy. He will continue to be paid in line with Chemring's remuneration policy and the treatment of all elements of his remuneration will be in line with the remuneration policy set out in the 2022 Annual Report and Accounts. Full details of all payments made to and receivable by Andrew Lewis will be disclosed on the Chemring website in due course in compliance with Section 430 (2B) of the Companies Act 2006 and in the directors' remuneration report within the Company's Annual Report and Accounts for the year ending 31 October 2023, and subsequent years, as appropriate.

 

www.chemring.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADGGDBGUDDGXD
Date   Source Headline
21st Jun 20161:12 pmRNSDirector/PDMR Shareholding
21st Jun 20167:00 amRNSINTERIM RESULTS
20th Jun 20162:39 pmRNSBlock listing Interim Review
20th Jun 20162:37 pmRNSBlock listing Interim Review
1st Jun 201611:01 amRNSTotal Voting Rights
17th May 20167:00 amRNSDirectorate Change
10th May 20164:20 pmRNSDirector/PDMR Shareholding
5th May 20167:00 amRNSCompletion of Acquisition
3rd May 201610:08 amRNSTotal Voting Rights
27th Apr 20162:13 pmRNSDirectorate Change
25th Apr 20169:52 amRNSDirector/PDMR Shareholding
19th Apr 20167:00 amRNSAPPOINTMENT OF CHAIRMAN-DESIGNATE
6th Apr 20164:15 pmRNSDirector/PDMR Shareholding
4th Apr 20167:00 amRNSContract Update
1st Apr 20169:48 amRNSTotal Voting Rights
24th Mar 201610:36 amRNSHolding(s) in Company
21st Mar 20162:05 pmRNSResult of AGM
21st Mar 201611:00 amRNSAGM Trading Update
8th Mar 20162:36 pmRNSDirector/PDMR Shareholding
7th Mar 20167:00 amRNSAPPOINTMENT OF NON-EXECUTIVE DIRECTOR
1st Mar 20165:26 pmRNSCorrection Re Holding in Company
1st Mar 20161:24 pmRNSTotal Voting Rights
26th Feb 201610:23 amRNSHolding(s) in Company
24th Feb 20168:48 amRNSResult of Rump Placing
23rd Feb 20163:03 pmRNSResults of Rights Issue
23rd Feb 201612:40 pmRNSHolding(s) in Company
19th Feb 20163:13 pmRNSDirector/PDMR Shareholding
9th Feb 20168:07 amRNSAdmission of Nil Paid Rights
8th Feb 201611:52 amRNSResult of EGM
4th Feb 201611:26 amRNSDirector/PDMR Shareholding
4th Feb 201611:25 amRNSDirector/PDMR Shareholding
1st Feb 201611:18 amRNSTotal Voting Rights
27th Jan 20167:00 amRNSDirector/PDMR Shareholding
21st Jan 20163:30 pmRNSPublication of Prospectus
21st Jan 20167:00 amRNS£80.8 million Rights Issue
21st Jan 20167:00 amRNSFinal Results
20th Jan 20164:01 pmRNSDirector/PDMR Shareholding
4th Jan 201610:01 amRNSTotal Voting Rights
21st Dec 201511:19 amRNSBlocklisting Update
21st Dec 201511:17 amRNSBlocklisting Interim Review
1st Dec 20159:57 amRNSTotal Voting Rights
25th Nov 20157:00 amRNSPOST-CLOSE STATEMENT
2nd Nov 201511:21 amRNSHolding(s) in Company
27th Oct 20157:00 amRNSTrading Statement
1st Oct 201511:15 amRNSTotal Voting Rights
29th Sep 20152:25 pmRNSHolding(s) in Company
14th Sep 20157:00 amRNSTrading Update
1st Sep 20159:33 amRNSTotal Voting Rights
20th Aug 20153:01 pmRNSHolding(s) in Company
7th Aug 20151:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.